APA (7th ed.) Citation

Leo Bon, Angelika Banaś, Inês Dias, Inês Melo-Marques, Sandra M. Cardoso, Sílvia Chaves, & M. Amélia Santos. (2024). New Multitarget Rivastigmine-Indole Hybrids as Potential Drug Candidates for Alzheimer's Disease. MDPI AG.

Chicago Style (17th ed.) Citation

Leo Bon, Angelika Banaś, Inês Dias, Inês Melo-Marques, Sandra M. Cardoso, Sílvia Chaves, and M. Amélia Santos. New Multitarget Rivastigmine-Indole Hybrids as Potential Drug Candidates for Alzheimer's Disease. MDPI AG, 2024.

MLA (9th ed.) Citation

Leo Bon, et al. New Multitarget Rivastigmine-Indole Hybrids as Potential Drug Candidates for Alzheimer's Disease. MDPI AG, 2024.